To compare intraoperative goal directed fluid therapy by trans-oesophageal Doppler vis-à-vis FloTrac™ in patients undergoing living related renal transplantation-a prospective randomised controlled study

Background: Optimal intra-operative fluid therapy in renal transplantation (RT) is essential to ensure adequate graft function while preventing fluid overload related complications. This RCT was to compare the intraoperative goal directed fluid therapy (GDFT) based either on corrected flow time (CFT...

Full description

Bibliographic Details
Main Authors: Ushkiran Kaur, Sandeep Sahu, Divya Srivastava, Tapas Kumar Singh, Prabhakar Mishra, Aneesh Srivastava
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Indian Journal of Anaesthesia
Subjects:
Online Access:http://www.ijaweb.org/article.asp?issn=0019-5049;year=2020;volume=64;issue=16;spage=220;epage=226;aulast=Kaur
_version_ 1818199002374471680
author Ushkiran Kaur
Sandeep Sahu
Divya Srivastava
Tapas Kumar Singh
Prabhakar Mishra
Aneesh Srivastava
author_facet Ushkiran Kaur
Sandeep Sahu
Divya Srivastava
Tapas Kumar Singh
Prabhakar Mishra
Aneesh Srivastava
author_sort Ushkiran Kaur
collection DOAJ
description Background: Optimal intra-operative fluid therapy in renal transplantation (RT) is essential to ensure adequate graft function while preventing fluid overload related complications. This RCT was to compare the intraoperative goal directed fluid therapy (GDFT) based either on corrected flow time (CFT), measured by trans oesophageal Doppler (TED) or on the stroke volume variation (SVV), by FloTrac in patients undergoing living donor RT. Methods: This prospective, randomised controlled trial (RCT) was done on 60 end stage renal disease (ESRD) patients, American Society of Anaesthesiologists(ASA) grade III–IV, age 18 to 65 years of either sex, scheduled for living donor RT under general anaesthesia. They were randomly divided into two groups: TED group (n = 30) and FloTrac™ group (n = 30) and administered GDFT, based upon CFT (TED) and SVV (FloTrac™). The primary outcome was to compare the total fluid and number of fluid boluses administered intraoperatively, while the secondary outcomes were to compare any postoperative complications due to fluid overload and allograft function, assessed by serial serum creatinine levels up to 90 days postoperatively. Results: The mean total intra-operative fluid [3991.67 ± 856.32 vs. 3543.33 ± 1131.35, P = 0.089] and the amount of fluid administered per kg body weight per hour [13.32 ± 4.67 vs. 11.82 ± 4.76, P = 0.222] were lesser in the FloTrac compared to TED group, though not statistically significant. However, the postoperative incidence of allograft dysfunction, including rejection (P = 0.743) and acute tubular necrosis (ATN) (P = 0.999), and other complications (P = 0.643) were comparable. Conclusions: Both TED and FloTrac devices can be used effectively to guide GDFT in RT, However, lesser total fluid was required in the FloTrac group, which may lead to a lesser number of fluid-related postoperative complications.
first_indexed 2024-12-12T02:14:50Z
format Article
id doaj.art-9d5181a43fc6471db478918481850065
institution Directory Open Access Journal
issn 0019-5049
0976-2817
language English
last_indexed 2024-12-12T02:14:50Z
publishDate 2020-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Anaesthesia
spelling doaj.art-9d5181a43fc6471db4789184818500652022-12-22T00:41:49ZengWolters Kluwer Medknow PublicationsIndian Journal of Anaesthesia0019-50490976-28172020-01-01641622022610.4103/ija.IJA_605_20To compare intraoperative goal directed fluid therapy by trans-oesophageal Doppler vis-à-vis FloTrac™ in patients undergoing living related renal transplantation-a prospective randomised controlled studyUshkiran KaurSandeep SahuDivya SrivastavaTapas Kumar SinghPrabhakar MishraAneesh SrivastavaBackground: Optimal intra-operative fluid therapy in renal transplantation (RT) is essential to ensure adequate graft function while preventing fluid overload related complications. This RCT was to compare the intraoperative goal directed fluid therapy (GDFT) based either on corrected flow time (CFT), measured by trans oesophageal Doppler (TED) or on the stroke volume variation (SVV), by FloTrac in patients undergoing living donor RT. Methods: This prospective, randomised controlled trial (RCT) was done on 60 end stage renal disease (ESRD) patients, American Society of Anaesthesiologists(ASA) grade III–IV, age 18 to 65 years of either sex, scheduled for living donor RT under general anaesthesia. They were randomly divided into two groups: TED group (n = 30) and FloTrac™ group (n = 30) and administered GDFT, based upon CFT (TED) and SVV (FloTrac™). The primary outcome was to compare the total fluid and number of fluid boluses administered intraoperatively, while the secondary outcomes were to compare any postoperative complications due to fluid overload and allograft function, assessed by serial serum creatinine levels up to 90 days postoperatively. Results: The mean total intra-operative fluid [3991.67 ± 856.32 vs. 3543.33 ± 1131.35, P = 0.089] and the amount of fluid administered per kg body weight per hour [13.32 ± 4.67 vs. 11.82 ± 4.76, P = 0.222] were lesser in the FloTrac compared to TED group, though not statistically significant. However, the postoperative incidence of allograft dysfunction, including rejection (P = 0.743) and acute tubular necrosis (ATN) (P = 0.999), and other complications (P = 0.643) were comparable. Conclusions: Both TED and FloTrac devices can be used effectively to guide GDFT in RT, However, lesser total fluid was required in the FloTrac group, which may lead to a lesser number of fluid-related postoperative complications.http://www.ijaweb.org/article.asp?issn=0019-5049;year=2020;volume=64;issue=16;spage=220;epage=226;aulast=Kaurcorrected flow timeflotrac™goal directed fluid therapyliving donor renal transplantationstroke volume variationtransoesophageal doppler
spellingShingle Ushkiran Kaur
Sandeep Sahu
Divya Srivastava
Tapas Kumar Singh
Prabhakar Mishra
Aneesh Srivastava
To compare intraoperative goal directed fluid therapy by trans-oesophageal Doppler vis-à-vis FloTrac™ in patients undergoing living related renal transplantation-a prospective randomised controlled study
Indian Journal of Anaesthesia
corrected flow time
flotrac™
goal directed fluid therapy
living donor renal transplantation
stroke volume variation
transoesophageal doppler
title To compare intraoperative goal directed fluid therapy by trans-oesophageal Doppler vis-à-vis FloTrac™ in patients undergoing living related renal transplantation-a prospective randomised controlled study
title_full To compare intraoperative goal directed fluid therapy by trans-oesophageal Doppler vis-à-vis FloTrac™ in patients undergoing living related renal transplantation-a prospective randomised controlled study
title_fullStr To compare intraoperative goal directed fluid therapy by trans-oesophageal Doppler vis-à-vis FloTrac™ in patients undergoing living related renal transplantation-a prospective randomised controlled study
title_full_unstemmed To compare intraoperative goal directed fluid therapy by trans-oesophageal Doppler vis-à-vis FloTrac™ in patients undergoing living related renal transplantation-a prospective randomised controlled study
title_short To compare intraoperative goal directed fluid therapy by trans-oesophageal Doppler vis-à-vis FloTrac™ in patients undergoing living related renal transplantation-a prospective randomised controlled study
title_sort to compare intraoperative goal directed fluid therapy by trans oesophageal doppler vis a vis flotrac™ in patients undergoing living related renal transplantation a prospective randomised controlled study
topic corrected flow time
flotrac™
goal directed fluid therapy
living donor renal transplantation
stroke volume variation
transoesophageal doppler
url http://www.ijaweb.org/article.asp?issn=0019-5049;year=2020;volume=64;issue=16;spage=220;epage=226;aulast=Kaur
work_keys_str_mv AT ushkirankaur tocompareintraoperativegoaldirectedfluidtherapybytransoesophagealdopplervisavisflotracinpatientsundergoinglivingrelatedrenaltransplantationaprospectiverandomisedcontrolledstudy
AT sandeepsahu tocompareintraoperativegoaldirectedfluidtherapybytransoesophagealdopplervisavisflotracinpatientsundergoinglivingrelatedrenaltransplantationaprospectiverandomisedcontrolledstudy
AT divyasrivastava tocompareintraoperativegoaldirectedfluidtherapybytransoesophagealdopplervisavisflotracinpatientsundergoinglivingrelatedrenaltransplantationaprospectiverandomisedcontrolledstudy
AT tapaskumarsingh tocompareintraoperativegoaldirectedfluidtherapybytransoesophagealdopplervisavisflotracinpatientsundergoinglivingrelatedrenaltransplantationaprospectiverandomisedcontrolledstudy
AT prabhakarmishra tocompareintraoperativegoaldirectedfluidtherapybytransoesophagealdopplervisavisflotracinpatientsundergoinglivingrelatedrenaltransplantationaprospectiverandomisedcontrolledstudy
AT aneeshsrivastava tocompareintraoperativegoaldirectedfluidtherapybytransoesophagealdopplervisavisflotracinpatientsundergoinglivingrelatedrenaltransplantationaprospectiverandomisedcontrolledstudy